10-Q: Non-Invasive Monitoring Systems Reports Continued Losses in Q2, Cites Going Concern Uncertainty
Quarterly Report
Non-Invasive Monitoring Systems, Inc. reports ongoing losses and expresses substantial doubt about its ability to continue as a going concern in its latest quarterly report.
Summary
- Non-Invasive Monitoring Systems, Inc. (NIMS) has released its Form 10-Q for the quarterly period ended January 31, 2024.
- The company is currently a shell company after discontinuing its operations in May 2019.
- NIMS reported net losses of approximately $142,000 and $119,000 for the six months ended January 31, 2024 and 2023, respectively.
- The company has an accumulated deficit of approximately $28,876,000 as of January 31, 2024.
- NIMS had approximately $75,000 of cash at January 31, 2024, and a negative working capital of approximately $183,000.
- The report indicates substantial doubt about the company's ability to continue as a going concern.
- The company is seeking potential mergers, acquisitions, and strategic collaborations.
- NIMS is also exploring obtaining additional promissory notes from related parties.
- General and administrative costs and expenses were $40,000 and $115,000 for the three and six months ended January 31, 2024, respectively, compared to $40,000 and $105,000 for the three and six months ended January 31, 2023.
- Net interest expense was $14,000 and $27,000 for the three and six months ended January 31, 2024, respectively, compared to $8,000 and $14,000 for the three and six months ended January 31, 2023.
- The company's disclosure controls and procedures were deemed not effective due to a material weakness related to segregation of duties and documentation of internal control procedures.
Sentiment
Score: 2
Explanation: The report paints a negative picture due to continued losses, a significant accumulated deficit, negative working capital, and doubts about the company's ability to continue as a going concern. The identified material weakness in internal control further contributes to the negative sentiment.
Negatives
- The company is currently a shell company with no active operations.
- NIMS has a history of operating losses and an accumulated deficit of $28,876,000.
- The company has negative working capital of $183,000.
- The report expresses substantial doubt about the company's ability to continue as a going concern.
- Disclosure controls and procedures were deemed not effective due to a material weakness.
Risks
- The company's history of operating losses and accumulated deficit pose a significant risk.
- The need for additional financing is a critical risk factor.
- The company's dependence on management is a risk.
- The company's ability to access capital in a timely manner is uncertain due to volatile economic conditions.
- The material weakness in internal control over financial reporting could lead to misstatements in financial statements.
Future Outlook
The company is assessing potential mergers, acquisitions, strategic collaborations and liquidation and is seeking additional financing through promissory notes from related parties; however, there is no assurance of success.
Industry Context
Given the company's status as a shell company and its focus on seeking strategic alternatives, its performance is not directly comparable to companies with active operations. The company's ability to secure financing and execute a strategic transaction will be critical for its future.
Related Party Transactions
- The company signed a five-year lease for office space in Miami, Florida, with a company controlled by Dr. Phillip Frost, who is the beneficial owner of more than 10% of the company's common stock; the lease currently continues on a month-to-month basis at no cost.
- On August 15, 2023, the Company entered into a Promissory Note in the principal amount of $200,000 with Frost Gamma Investments Trust, a trust controlled by Dr. Phillip Frost, which beneficially owns in excess of 10% of the Company's common stock.
- On September 16, 2022, the Company entered into two Promissory Notes in the principal amount of $75,000 each with Frost Gamma Investments Trust, a trust controlled by Dr. Phillip Frost, a current director, and with Jane Hsiao, Ph.D., the Company's Chairman and Interim CEO, both which beneficially own in excess of 10% of NIMS common stock.
- On October 4, 2021, the Company entered into two Promissory Notes in the principal amount of $75,000 each with Frost Gamma Investments Trust, a trust controlled by Dr. Phillip Frost, a current director, and with Jane Hsiao, Ph.D., the Company's Chairman and Interim CEO, both which beneficially own in excess of 10% of NIMS common stock.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial condition and going concern uncertainty.
- Employees are impacted by the company's limited operations and uncertain future.
- Creditors face increased risk of non-payment due to the company's financial difficulties.
Next Steps
- The company is seeking potential mergers, acquisitions, and strategic collaborations.
- The company is exploring obtaining additional promissory notes from related parties.
Key Dates
| Date | Description |
|---|---|
| 2007-12-30 | Dr. Phillip Frost became a member. |
| 2008-01-01 | Dr. Phillip Frost became a member. |
| 2008-01-01 | Miami office lease commenced. |
| 2012-12-31 | Miami office lease expired. |
| 2016-02-01 | Dr. Phillip Frost became a member. |
| 2016-02-29 | Dr. Phillip Frost became a member. |
| 2019-05-03 | Company exchanged inventory for forgiveness of accrued unpaid rent. |
| 2019-05 | The Company discontinued operations. |
| 2021-10-03 | Company entered into two Promissory Notes. |
| 2021-10-04 | Company entered into two Promissory Notes. |
| 2022-07-31 | End of period for comparative balance sheet data. |
| 2022-08-01 | Start of period for comparative financial data. |
| 2022-09-15 | Company entered into two Promissory Notes. |
| 2022-09-16 | Company entered into two Promissory Notes. |
| 2022-10-31 | End of period for comparative financial data. |
| 2022-11-01 | Start of period for comparative financial data. |
| 2023-01-31 | End of period for comparative financial data. |
| 2023-07-31 | End of fiscal year 2023. |
| 2023-08-01 | Start of current reporting period. |
| 2023-08-15 | Company entered into a Promissory Note. |
| 2023-10-31 | End of period for comparative financial data. |
| 2023-11-01 | Start of period for comparative financial data. |
| 2024-01-31 | End of current reporting period. |
| 2024-03-15 | Date of report and outstanding shares. |
| 2025-07-31 | Maturity date of Promissory Notes. |
Keywords
Non-Invasive Monitoring Systems, NIMS, Form 10-Q, Quarterly Report, Going Concern, Shell Company, Losses, Deficit, Related Party Transactions, Internal Control, Promissory Notes, Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.